Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
March 5, 2026
Technology
-
-
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
March 4, 2026
-
Ypsilanti Deploys Beam Global Resilient Energy Products to Counter Grid Interruptions Amid Rising Oil Prices and Energy Volatility
March 4, 2026
-
Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program
March 4, 2026
-
Trio-Tech International Secures Production Burn-In Order from a Leading Integrated Device Manufacturer, Strengthening its Automotive Semiconductor Market Presence
March 4, 2026
-
AudioEye Advances Next-Generation Digital Accessibility Platform, Delivering the Industry’s Strongest Compliance Protection
March 4, 2026
-
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
March 4, 2026
-
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
March 4, 2026
-
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
March 4, 2026
-
HUB Cyber Security Ltd. (Nasdaq: HUBC) Highlights Tivani Expansion Into Defense-Grade Strategic Minerals
March 4, 2026
-
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference
March 3, 2026
-
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
March 3, 2026
-
Upland Software Reports Fourth Quarter 2025 Financial Results
March 3, 2026
-
Duos Technologies Group, Inc. Announces Closing of $65 Million Public Offering of Common Stock
March 3, 2026
-
Flexitech Chooses Rimini Street to Extend the Life of its SAP ECC, Accelerate Compliance and Fund Innovation
March 3, 2026
-
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
March 3, 2026